Answers are grounded in this paper and cite their sources.
Clinicalmicrobiology ispoised tomove into adynamic ageby embracing molecular diagnostic techniques, such as polymerase chain reaction–based amplification techniques and whole-genome sequencing (WGS). These technologies will revolutionize data acquisition for theranostics and the tracking of outbreaks. Whole-genome sequencing originally proved its worth through investigations of infectious agents.1 In this issue of JAMA Internal Medicine, Reuter et al2 now advocate WGS for routine diagnostics and public health microbiology. These ideas arenot as far-fetchedas they may initially sound. Although the cost and time to conductWGSwouldhaveoncebeenprohibitive,abacterialWGS can be performed for less than $100 in 1 day’s time.Moreover, the computational systems forperforming theanalytics on the WGSdata allow for rapid turnaround times.Collectively, these metrics make WGS competitive with any technology, including traditional methods of culturing bacteria. Although there arenocommercialWGSanalytics thatcould integratewithstandard laboratory informationsystemsnow,suchtoolswill bedeveloped that canaccess cloud-basedcomputing resources containingglobalstraindatabasesannotatedwithrespect toclinical origins, spread, and associated symptoms.
No takes yet. Share an insight, caveat, or question.
Ehrlich et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: